let function, as associated with acetylsalicylic acid ingestion, uremia, or von Willebrand's disease. In contrast, bleeding times shorter than predicted with normal platelets are due to increased hemostatic competence of young platelets, associated either with idiopathic thrombocytopenic purpura or with bonemarrow recovery after chemotherapy. The standardized bleeding time measures the overall hemostatic role of platelets in vivo, and is thus suitable for systematic screening.
The bleeding time, platelet count, platelet size and in vitro platelet function were determined in 136 patierits assigned to eight different categories: 70 patients with stable thrombocytopenia due to acquired impairment of platelet production (druginduced or idiopathic) who were receiving no medications during the preceding week (five of these patients who had platelet counts below 10,000 per microliter and bleeding times greater than 60 minutes were studied after freshly prepared platelet concentrates were transfused from normal donors); 11 patients with modest thrombocytopenia due to splenomegaly (cirrhosis of the liver in four patients, myeloid metaplasia in two, Gaucher's disease in two, and lymphoma in three); 10 patients from four different kindreds with autosomal dominant hereditary thrombocytopenia; 12 patients with a diagnosis of idiopathic thrombocytopenic purpura (ITP) (criteria included thrombocytopenia for at least six months in association with increased megakaryocyte number and size, shortened platelet survival with a documented response to steroid therapy, and no other known associated pathologic process)5; five patients with cancer and normal platelet counts who received experimentally 60 mg per kilogram of intravenous cyclophosphamide on two consecutive days; nine patients with von Willebrand's disease (diagnosis based on low circulating factor VIII levels that responded to cryoprecipitate maximally 18 to 20 hours after infusion, and decreased platelet retention by glass-bead columns); 15 patients with chronic uremia (three without dialysis, four receiving peritoneal dialysis, and eight maintained with hemodialysis); and four patients with WiscottAldrich syndrome (congenital thrombocytopenia, dermatitis, recurrent infections and defective immune mechanism). 
METHODS

Subjects Inve §tigated
Measurements of bleeding time and platelet count were performed on 100 normal, young adult males, who denied taking any medication during the preceding two weeks. Ten of these subjects were subsequently "given 0.6 g of acetylsalicylic acid (ASA) daily for two days, and the studies were repeated. The same 10 subjects were later given 3 g of ASA daily for two days, and studied over the following eight days.
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RESULTS
Effect of Platelet Count on Bleeding Time
The bleeding time:f: in 100 nornlal subjects with a mean platelet count of 250,000 ::t: 40,000 platelets per microliter was 4.5 ::t: 1.5 minutes. In patients with thrombocytopenia due to impaired production, bleeding times remained in the normal range until the concentration of platelets feQ below 100,000 per microliter. At counts below 11;>,000 platelets per microliter, bleeding times exceeded 30 minutes. Between these platelet levels the bleeding time had a direct inverse relation with the concentration of circulating platelets (Fig. 1) . The correlation coefficient was 0.971 (p less than 0.001), and the regression line was represented by y = -3850x + 117,500 (standard error of the estimate was 7220, and the standard error of the slope was 141). Normal platelets transfused into five Unimm " nized recipients with aplastic thrombocytope (platelet counts less than 10,000 per microliter) predictably shortened the bleeding time in ---with the elevation achieved in the platelet -- (Fig. 2) . Furthermore, the expected relation tween platelet count and bleeding time . -~ "--., tained as the platelet count progressively fell ove! the next four or five days.
Bleeding times also correlated with platelet col!" centration in 11 patients whose thrombocytopenw as related to massive splenomegaly and the assoet ated increased platelet sequestration (Fig. 3 ). SilJ)J; larly, the normal relation between bleeding til1le and platelet count applied to 10 patients with hii' reditary thrombocytopenia (Fig. 3) .
Effect of Young Platelets on Bleeding Time
In 12 patients with ITP and a mean platelet count ;AII variances are given as z I S.D.
Laboratory Studies
Performan<:e of the bleeding time involved maintenance of venous pressure at 40 mm of mercury with a sphygmomanometer, triplicate template standardized incisions of I-mm depth and 9-mm length in previously cleansed volar skin of the forearm. The time required for cessation of bleeding was then measured by blotting with filter paper every 30 se<:onds without disturbing the wound. 4 To avoid visible scarring, incisions were made in a longitudinal direction, and the edges of the wound were held together for 48 hours with butterfly tapes on completion of the test. The template gauge and blade holder were machined from stainless steel to facilitate proper sterilizing for reuse. Placement and adjustment of a disposable blade were simplified by incorporation of the hub of a surgical knife handle and a positioning screw in the blade holder.
Platelet counts were measured with an electronic particle counter on peripheral blood collected in EDT A by means of a previously described method6 adapted from Bull, Schneiderman and Brecher. 7 Platelet volume was estimated by means of an electronic particle-sizing apparatus (Coulter Counter) after the method of Bull and Zucker,K which involves testing platelet-rich plasma prepared by sedimentation of ACD-drawn blood at 37°C and diluted in Eagle's solution.* Monosized latex parti<:les (volume 3.86 JL3) were used for standardization. We calculated an index of platelet volume by dividing the patient's mean platelet volume by the mean normal platelet volume.
Platelet aggregation was estimated from changes in optical transmissiont of 0.02 M sodium <:itrated plasma at 37°C with a concentration of 300 000 platelets per mi<:roliter within 70 minutes of draw'ing. Aggregation was observed in I-ml aliquots after the addition of ADP (0.25, 0.50, 0.75, 1.00 and 5.00 JLg), thrombin (0.2 NIH units), <:ollagen and epinephrine (2.5 JLg).9,IO Plastic equipment was used throughout, and plasma, freshly drawn, was kept at room temperature before testing. Platelet adhesion to glass beads was measured b)7 the modified Salzman method.11 In this procedure 7 ml of blood is drawn into a plastic syringe without anticoagulant and immediately passed through the standard column of beads with a constant infusion pump at the rate of 2 ml per minute. The delay between blood drawing and initiation of flow through the beads was less than 10 seconds. Platelet counts in four serial 1-ml samples of effluent blood were compared with the circulating platelet count. In 35 normal subjects, 40 ::t; 9 per cent (::t; 1 S.D.) of the platelets in the first sample and 79 ::t; 12 per cent in the fourth sample remained adherent in the column of glass beads. Platelet adhesion to collagen was evaluated by direct counts 12 and by optical-density measurement.13 Platelet phospholipid availability (platelet factor 3) was estimated by comparison of kaolin recalcification times of platelet-poor plasma with a plasma suspension of platelets standardized at a count of 50,000 platelets per microliter.14 Clot retraction was measured as the amount of serum ' Coulter Counter, Hialeah, Fla. tAl!l!rel!ometer, Chromo-Log, Inc., Broomall, Pa. (8) or Rapidly Returning BoneMarrow Function after Chemotherapy ("'). Bleeding times remain short even after adjustment for the increase in platelet volume (0). Impaired platelet plug formation is reflected as bleeding times longer than predicted by the platelet count as shown by 3 g of ASA daily (0) and von Willebrand's disease (0), which corrects with cryoprecipitate infusion .). In uremia platelets have marked dysfunction in the untreated state ("'). which improves after hemodialysis (V) and reverses to normal with peritoneal dialysis 1""). The modestly disparate bleeding times in Wiscott-Aldrich syndrome (WAS) (A) become appropriate after adjustment for the small platelet volume (l;). 
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Five patients undergoing transient bone-marrow suppression from high-dose cyclophosphamide showed a progressive fall in the platelet count and predictable prolongation of bleeding times. Heralding the return of marrow function, the bleeding time shortened to normal values before any rise in the platelet count was observed (Fig. 4) . Based on concomitant measurements of platelet survival and platelet counts, the bleeding time shortened when the newly released platelets approximated a concentration of 25,000 per microliter of circulating blood. Platelet volume was not measurably increased at this time.
'/. oH7,OOO:!: 9,900 per microliter, the bleeding time averaged 6.9 :!: 2.6 minutes, which was much shorter than expected from the platelet count (Fig. 4) . Even with adjustment of the platelet count to reflect the 1.4 X normal increase in platelet volume,* bleeding times remained significantly shorter (p less tha~ 0.001) than the 24 minutes predicted on the aSlS of normally functioning platelets.
Effect of Platelet Dysfunction on Bleeding Time
Bleeding times were prolonged to 9.4 :t 2.3 minutes in the 10 normal subjects ingesting 0.6 g of ASA per day for two days (p less than 0.01). A daily dose of 3.0 g of ASA for two days further lengthened the bleeding time in all these subjects (Fig. 4) to a mean of 14.5 :t 2.6 minutes (p less than 0.01). The effect on the bleeding time diminished gradually, so that base-line values were reached four days after medication was stopped. Inhibitory effects were also noted on ADP-induced and epinephrine-induced secondary platelet aggregation and platelet adhesion to collagen fibers, although these results were less predictable.
In three patients with severe chronic uremia the 'Platelet count X platelet volume index bleeding time was greater than 60 minutes. Conversely, peritoneal dialysis management of uremia in four other patients resulted in normalization of the bleeding times (5.3 :!: 1.0 minutes). In eight uremic patients maintained by hemodialysis the bleeding time was 20.4 :!: 2.6 minutes (Fig. 4) ; modification of the dialysis program to a low-flow dialysis regimen (100 ml per minute instead of 500 ml per minute) shortened the bleeding time to 7.4 :!: 2~1 minutes. Changes in platelet retention by glass-bead column and platelet adhesion to collagen fibers paralleled the alterations in bleeding time, although with greater variability. In nine patients with von Willebrand's disease, the mean bleeding time was 41.4 :!: 10.8 minutes (Fig. 4) . In two of these patients transient correction of the bleeding time to normal followed the infusion of 15 bags of cryoprecipitate (Fig. 4) .
Bleeding times in four patients with WiscottAldrich syndrome averaged 28.3 :!: 3.4 minutes, which was longer than expected for the platelet count. However, when their platelet counts were adjusted for the decrease in platelet size (platelet index, 0.6), bleeding times appeared to correlate appropriately (Fig. 4) . £tInction with the bleeding time is also illustrated by the uremic patients, in whom the marked prolongation before treatment improved greatly with hemodialysis therapy, and was completely corrected by peritoneal dialysis, apparently reflecting the difference in efficiency of artificial and physiologic dialyzing membranes, respectively.20 In accord with published observations, the bleeding time reliably detects pathologically impaired platelet plug formation associated with hereditary disorders of platelet function involving both the extrinsic disorders (e.g.., von Willebrand's disease) and intrinsic abnormalities (e.g., thrombasthenia).2J-24 Although the bleeding time in Wi scott -Aldrich syndrome is 'abnormally prolonged in terms of platelet numbe'r, function appears normal when related to platelet mass (Fig. 4) .
The unexpected shortening of the bleeding time in patients with ITP suggests that these platelets have enhanced hemostatic capacity; these results are in agreement with animal and in vitro studies.2",26 Although these young platelets are of increased size, significant functional enhancement is evident even after platelet-mass correction (Fig. 4) . The increased functional integrity of young platelets is further evidenced by the shortening of the bleeding time to normal with returning marrow function after cyclophosphamide suppression (Fig. 4) .
On the basis of these studies, the standardized template bleeding time is considered a valuable measure of the platelet's role in hemostasis with sufficient sensitivity and reliability to serve as the best clinical screening test of platelet function. It is particularly useful in the systematic evaluation of patients with thrombocytopenia because of its capacity to discriminate between platelets with normal and those with decreased or increased function.
DISCUSSION
The observations in patients with acquired hypoproliferative thrombocytopenia indicate that platelet plug formation is unimpaired when normal platelets circulate at levels of 100,000 per microliter or higher. At lesser concentrations, however, bleeding is inversely related to the platelet count (Fig. 1) . This relation is valid down to a platelet level of 10,000 per microliter, in the absence of interfering medications or disease. The precision of this relation is verified by the predictable shortening of the bleeding time produced by transnlsed fresh normal platelets into aplastic recipients (Fig. 2) . The effect of normal platelets on the bleeding time between concentrations of 100,000 and 10,000 per microliter is expressed by the equation: The template bleeding time therefore appears to be a useful measure of platelet hemostatic function in vivo, and applies to thrombocytopenia due not only to marrow failure but also to other conditions, such as splenomegaly (Fig. 3) . These data indicate that the platelets left in circulation by an enlarged spleen function normally, find~ngs at variance with observations by Shulman et al.ls Similarly, the platelets that circulate in patients with autosomal dominant thrombocytopenia function normally (Fig. 3) although the concentration is reduced as a result of defective thrombopoiesis. 16 Studies with ASA demonstrate the sensitivity of the bleeding time for detecting platelet dysfunction.4,17-19 When normal subjects ingest 0.6 g of ASA, the bleeding time doubles, whereas a 3-g daily dose in the same subjects produces a threefold prolongation (Fig. 4) . The usefulness of monitoring platelet "Derived from the regression line y =-3850x + 117,500 (Fig, 1) by solving for the bleeding time "x",
